Effect of Shugan Hewei Granules on reflux esophagitis of stagnant heat in liver and stomach syndrome

Ahui WANG; Shengliang ZHU; bingduo ZHOU; Yi WANG; Yading LI

doi:10.16305/j.1007-1334.2021.2011142

您当前的位置：

首页 >

文章列表页 >

Effect of Shugan Hewei Granules on reflux esophagitis of stagnant heat in liver and stomach syndrome

更新时间：2022-08-03

- Effect of Shugan Hewei Granules on reflux esophagitis of stagnant heat in liver and stomach syndrome
- Shanghai Journal of Traditional Chinese Medicine Vol. 55, Issue 3, Pages: 57-60(2021)
- 作者机构：
  
  1.上海中医药大学附属岳阳中西医结合医院消化科（上海　200437）
- 作者简介：
- 基金信息：
- DOI：10.16305/j.1007-1334.2021.2011142
  CLC：
扫描看全文
Ahui WANG, Shengliang ZHU, bingduo ZHOU, et al. Effect of Shugan Hewei Granules on reflux esophagitis of stagnant heat in liver and stomach syndrome. [J]. Shanghai Journal of Traditional Chinese Medicine 55(3):57-60(2021)
DOI：

Ahui WANG, Shengliang ZHU, bingduo ZHOU, et al. Effect of Shugan Hewei Granules on reflux esophagitis of stagnant heat in liver and stomach syndrome. [J]. Shanghai Journal of Traditional Chinese Medicine 55(3):57-60(2021) DOI： 10.16305/j.1007-1334.2021.2011142.

摘要

目的,2,评价疏肝和胃颗粒治疗肝胃郁热型反流性食管炎的临床疗效。,方法,2,将94例肝胃郁热型反流性食管炎患者随机分为试验组和对照组，每组47例。试验组予生活饮食指导合疏肝和胃颗粒，对照组予生活饮食指导合奥美拉唑。两组疗程均为8周，观察临床疗效、临床症状积分以及胃镜下食管黏膜分级变化情况。,结果,2,入组患者94例均完成了8周疗程，其中疗程结束后实际完成胃镜复查76例。试验组临床及胃镜总有效率分别为95.74%、80.00%，对照组分别为76.60%、63.89%，试验组临床疗效及胃镜疗效均优于对照组（,P,<,0.05）。两组治疗后，临床症状积分值均显著降低（,P,<,0.05）；组间治疗后临床症状积分差值比较，差异有统计学意义（,P,<,0.05）。两组治疗后，胃镜下食管黏膜炎症分级均明显改善（,P,<,0.05）；组间治疗后比较，胃镜下食管黏膜炎症分级差异有统计学意义（,P,<,0.05）。,结论,2,疏肝和胃颗粒可以明显提高肝胃郁热型反流性食管炎的临床疗效，改善临床症状，减轻食管黏膜炎症。

Abstract

Objective,2,To evaluate the clinical effect of Shugan Hewei Granules on reflux esophagitis of stagnant heat in the liver and stomach syndrome.,Methods,2,Totally 94 patients suffering from reflux esophagitis of stagnant heat in the liver and stomach syndrome were randomly divided into test group (,n,=47) and control group (,n,=47). The test group was treated with Shugan Hewei Granules and the control group was treated with omeprazole; the course of treatment in both groups was 8 weeks, and the clinical therapeutic effect, clinical symptom score and esophageal mucosal grading under gastroscopy were observed.,Results,2,All 94 enrolled patients completed the 8-week course of treatment, and 76 of them actually completed the gastroscopy review after the course of treatment. The total effective rates of the treatment and improvement of esophageal mucosal inflammation under gastroscopy in the test group were 95.74% and 80.005% respectively, while those in the control group were 76.60% and 63.89% respectively. The clinical therapeutic effect and the improvement of esophageal mucosal inflammation under gastroscopy in the test group were better than those in the control group (,P,<,0.05).After treatment, the clinical symptom scores of the two groups decreased significantly (,P,<,0.05), and there was significant difference in the clinical syndrome scores between the two groups after treatment (,P,<,0.05). After treatment, the grade of esophageal mucosal inflammation significantly improved in both groups (,P,<,0.05), and there was significant difference in the grade of esophageal inflammation under gastroscopy between the two groups after treatment (,P,<,0.05).,Conclusion,2,Shugan Hewei granules has obvious clinical effect on reflux esophagitis of stagnant heat in the liver and stomach syndrome, as it can improve clinical symptoms and reduce esophageal mucosal inflammation.

关键词

反流性食管炎肝胃郁热型疏肝和胃颗粒临床疗效

Keywords

reflux esophagitispattern of stagnant heat in liver and stomachShugan Hewei granulesclinical efficacy

references

中国中西医结合学会消化系统疾病专业委员会. 胃食管反流病中西医结合诊疗共识意见(2017年)[J]. 中国中西医结合消化杂志,2018, 26(3): 221-226,232.

阿孜古力·阿不来提，梁灿灿，纪文静，等. 质子泵抑制剂治疗反流性食管炎的预后影响因素分析[J]. 国际消化病杂志,2019, 39(6): 428-431.

张瑞明，任顺平. 柴平汤加味联合雷贝拉唑肠溶胶囊治疗反流性食管炎肝胃郁热证的临床观察[J]. 中国中西医结合消化杂志,2019, 27(12): 902-905.

中华医学会消化病学分会. 2014年中国胃食管反流病专家共识意见[J]. 中华消化杂志,2014, 34(10): 649-661.

ARMSTRONG D, BENNETT J R, BLUM A L, et al. The endoscopic assessment of esophagitis: a progress report on observer agreement[J]. Gastroenterology,1996, 111(1): 85-92.

中华中医药学会脾胃病分会. 胃食管反流病中医诊疗专家共识意见(2017)[J]. 中国中西医结合消化杂志,2017, 25(5): 321-326.

徐亭亭,朱生樑. 疏肝和胃方治疗非糜烂性胃食管反流病疗效观察[J]. 时珍国医国药,2017, 28(5): 1135-1136.

FOCK K M, TALLEY N, GOH K L, et al. Asia.Pacific consensus on the management of gastro-esophageal reflux disease: an update focusing on refractory reflux disease and Barrett’s oesophagus[J]. Gut, 2016, 65(9): 1402-1415.

吕宾. 难治性胃食管反流症状一定是胃食管反流病吗?[J]. 胃肠病学,2017, 22(3): 129-132.

SONG I J, KIM H K, LEE N K, et al. Prospective single arm study on the effect of ilaprazole in patients with heartburn but no reflux esophagitis[J]. Yonsei Med J, 2018, 59(8): 951-959.

KIM A, PARK W Y, SHIN N, et al. Cardiac mucosa at the gastroesophageal junction: An Eastern perspective[J]. J Gastroenterol, 2015, 21(30): 9126-9133.

RIBEIRO A R, DINIZ P B, PINHEIRO M S, et al. Gastroprotective effects of thymol on acute and chronic ulcers in rats: The role of prostaglandins, ATP-sensitive K(+) channels, and gastric mucus secretion[J]. Chem Biol Interact, 2016(244): 121-128.

EL-SERAG H B, SWEET S, WINCHESTER C C, et al. Update on the epidemiology of gastroesophageal reflux disease: a systematic review[J]. Gut, 2013, 63(6): 871-880.

韩菲，张晓岚. 胃食管反流病的药物治疗[J]. 临床荟萃,2017, 32(1): 17-21.

中华中医药学会脾胃病分会. 胃食管反流病中医诊疗共识意见（2009，深圳）[J]. 中医杂志,2010, 51(9): 844-847.

汤瑾，王宏伟，郭健，等. 胃食管反流病中医诊疗方案的疗效验证[J]. 上海中医药大学学报,2011, 25(3): 40-42.

王轶，潘旭娣，朱生樑. 非糜烂性反流病中医证候特点及疗效分析[J]. 辽宁中医药大学学报,2018, 20(8): 180-184.

朱生樑，孙永顺，马淑颖，等. 胃食管反流病中医证候的多元分析[J]. 上海中医药杂志,2006, 40(10): 28-29.

马淑颖，朱生樑，孙永顺，等. 疏肝和胃方治疗酸碱混合反流性食管炎45例临床观察[J]. 上海中医药杂志,2006, 40(4): 24-25.

程艳梅，王高峰，王宏伟，等. 疏肝和胃方对反流性食管炎模型大鼠环氧合酶-2及前列腺素E2的影响[J]. 江西中医药,2012, 43(7): 60-62.

AZER S A, REDDIVARI A. Reflux esophagitis[M].Treasure Island(FL): StatPearls, 2020.

ANTUNES C, ALEEM A, CURTIS S A. Gastroesophageal reflux disease[M].Treasure Island(FL): StatPearls, 2020.

Views

178

下载量

CSCD

CNKI被引量

Alert me when the article has been cited

提交

Tools

Publicity Resources

Research progress in anti⁃tumor clinical efficacy and mechanism of action of Sarcandrae Herba

Meta-analysis on efficacy and safety of Ginkgo Folium extract in treating diabetic kidney disease

Meta⁃analysis of efficacy and safety of Dachengqi Decoction combined with octreotide and conventional therapy for early postoperative inflammatory small bowel obstruction

Efficacy and safety of Yiqi Yangyin Jiedu regimen plus anlotinib in the treatment of advanced non⁃small cell lung cancer

Observation on curative effect of three fixation methods for treatment of distal radius extension fractures in the middle-aged and elderly

Related Author

No data

Related Institution

Sichuan Institute for Translational Chinese Medicine

Shanghai University of Traditional Chinese Medicine

The Second Clinical Medical College of Henan University of Chinese Medicine

Department of Nephropathy， Henan Province Hospital of Traditional Chinese Medicine， The Second Hospital Affiliated to Henan University of Chinese Medicine

School of Public Health and Health Sciences， Tianjin University of Traditional Chinese Medicine

⁰